Indaptus Therapeutics
INDP
19 hedge funds and large institutions have $1.26M invested in Indaptus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
27% more funds holding
Funds holding: 15 → 19 (+4)
0.01% more ownership
Funds ownership: 0.25% → 0.25% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
4% less capital invested
Capital invested by funds: $1.31M → $1.26M (-$51.8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$52.6K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.8K |
| 3 |
Renaissance Technologies
New York
|
+$1.2K |
| 4 |
BHWM
Beaird Harris Wealth Management
Dallas,
Texas
|
+$730 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$199 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$32K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.92K |
| 3 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
-$199 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$133 |
INDP Hedge Fund Activity: Q2 2024 in Review
19 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2024, worth a combined $1.26M — down 3.9% from $1.31M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new INDP positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $52.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $32K sold.
- 19 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2024, up from 15 in Q1 2024.
- Funds reported $1.26M of Indaptus Therapeutics stock for Q2 2024, down 3.9% quarter-over-quarter.
- 5 funds opened new Indaptus Therapeutics positions in Q2 2024 and 1 closed out, a net change of +4 holders.
- The largest Indaptus Therapeutics buyer in Q2 2024 was Citadel Advisors, an estimated $52.6K added.
- The largest Indaptus Therapeutics seller in Q2 2024 was Virtu Financial, an estimated $32K sold.
Based on aggregated 13F filings for Q2 2024.